AsiaTIDES: Oligonucleotide and Peptide Therapeutics

Find R&D Innovations, Technologies and Partners to Advance Oligonucleotides and Peptides from Discovery through Manufacturing and Commercialization.

Day One

  • Optional Workshop: Accelerating Oligonucleotides to IND and Beyond
  • Optional Workshop: An Introduction to Peptide Therapeutic Development: Strategies for Moving to the Clinic, CMC and Beyond
  • Plenary Keynote Presentations from Alnylam Pharmaceuticals, Novo Nordisk A/S, Ionis Pharmaceuticals, The University of Tokyo, Agilent Technologies
  • Networking Dinner in Tokyo

Day Two

  • Featured mRNA Therapeutics Session with speakers from Moderna Therapeutics, BioNTech AG, and CureVac AG
  • Oligonucleotide Track: Optimizing Properties of Oligonucleotides/Oligonucleotide CMC Strategies
  • Peptide Track: Peptide Discovery and Peptide Drug Targets/Peptide Synthesis/Optimizing Peptide Properties
  • Evening Cocktail Networking Reception

Day Three

  • NEW Regulatory Session from Fountain Medical Development, Regulatory Consulting, PPD, and Biologics Consulting Group
  • Oligonucleotide Track: Delivery Strategies/Preclinical and Clinical Case Studies
  • Peptide Track: Peptide CMC Strategies/Preclinical and Clinical Case Studies

 Event Details 

Start Date
Feb 26, 2019
End Date
Feb 28, 2019
Venue
Hilton Tokyo Bay Hotel,
Tokyo,
Japan
Website
https://lifesciences.knect3...